ADVERTISEMENT
A vet and technician take a sample from a dog for use in PetDx’s OncoK9 test, which screens cell-free DNA for genomic alterations associated with cancer.
The Pet Health Industry Takes on Canine Cancer
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
The Pet Health Industry Takes on Canine Cancer
The Pet Health Industry Takes on Canine Cancer

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.

cancer, biobusiness

Natural Killer Cell Therapies Catch Up to CAR T
Bianca Nogrady | Apr 1, 2020 | 8 min read
There’s a new cell-based cancer immunotherapy on the block.
small-molecule therapeutics treat cancer and other diseases
Scientists Take Aim at Disease-Causing RNAs Using Small-Molecule Drugs
Claire Asher | Apr 1, 2019 | 9 min read
Renewed interest from the biotech industry sparks hope for drugging the nucleic acid to treat cancer and other conditions.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018 | 9 min read
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
Direct-to-Consumer Liquid Biopsy
Kerry Grens | Sep 13, 2015 | 2 min read
Some doctors advise shoppers to be skeptical of a newly marketed cancer diagnostic.
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015 | 1 min read
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
Take Two of These
Bob Grant | Jun 22, 2011 | 6 min read
Drugmakers are teaming up to test the disease-fighting power of combination therapies earlier in the development cycle than ever before.
ADVERTISEMENT